第三次全国幽门螺杆菌感染若干问题共识报告(2007·庐山)

被引：118

作者：

胡伏莲

胡品津

刘文忠

王继德

吕农华

萧树东

张万岱

成虹

谢勇

机构：

[1] 中华医学会消化病学分会幽门螺杆菌学组/幽门螺杆菌科研协作组

来源：

现代消化及介入诊疗 | 2008年 / 01期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

100201 [内科学];

摘要：

<正>迄今为止,我国已发布了两次关于幽门螺杆菌(H.pylori)若干问题的共识意见,第一次是1999年海南三亚会议提出的海南共识,于2000年发表;第二次是2003年安徽桐城会议提出的桐城共识,于2004年发表。其后,我国对H.pylori处理中的一些重要问题又有了新的认识和见解,欧洲2000年MaastrichtⅡ和2005年MaastrichtⅢ共识报告对我们也有所启示,故中华医学会消化病学分会H.pylori学组于

引用

页码：73 / 76

页数：4

共 21 条

[1]

Meta-analysis:: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori [J].

Fischbach, L. ;

Evans, E. L. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (03) :343-357

[2]

High eradication rate of H. pylori with moxifloxacin-based treatment: a randomized controlled trial.[J]..Wiener klinische Wochenschrift.2007, 11

[3]

Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures [J].

Gisbert, J. P. ;

Gisbert, J. L. ;

Marcos, S. ;

Moreno-Otero, R. ;

Pajares, J. M. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (10) :1469-1474

[4]

Efficacy of moxifloxacin-based triple therapy as second-line treatment for Helicobacter pylori infection [J].

Cheon, JH ;

Kim, N ;

Lee, DH ;

Kim, JM ;

Kim, JS ;

Jung, HC ;

Song, IS .

HELICOBACTER, 2006, 11 (01) :46-51

[5]

Improved efficacy of 10-day sequential treatment for Helicobacter pylori eradication in children:: a randomized trial [J].

Francavilla, R ;

Lionetti, E ;

Castellaneta, SP ;

Magistà, AM ;

Boscarelli, G ;

Piscitelli, D ;

Amoruso, A ;

Di Leo, A ;

Miniello, VL ;

Francavilla, A ;

Cavallo, L ;

Ierardi, E .

GASTROENTEROLOGY, 2005, 129 (05) :1414-1419

[6]

American gastroenterological association technical review on the evaluation of dyspepsia [J].

Allison, JA ;

Inadomi, JM ;

Ladabaum, U ;

McQuaid, K ;

Metz, D .

GASTROENTEROLOGY, 2005, 129 (05) :1756-1780

[7]

Update on therapeutic options for Helicobacter pylori-related diseases [J].

Mégraud F. .

Current Infectious Disease Reports, 2005, 7 (2) :115-120

[8]

Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection [J].

Nista, EC ;

Candelli, M ;

Zocco, MA ;

Cazzato, IA ;

Cremonini, F ;

Ojetti, V ;

Santoro, M ;

Finizio, R ;

Pignataro, G ;

Cammarota, G ;

Gasbarrini, G ;

Gasbarrini, A .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (10) :1241-1247

[9]

A negative rapid urease test is unreliable for exclusion of Helicobacter pylori infection during acute phase of ulcer bleeding.[J].D Schilling;A Demel;H.E Adamek;T Nüsse;E Weidmann;J.F Riemann.Digestive and Liver Disease.2003, 4

[10]

An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia:: Resolving the discrepancy between systematic reviews [J].

Moayyedi, P ;

Deeks, J ;

Talley, NJ ;

Delaney, B ;

Forman, D .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (12) :2621-2626

← 1 2 3 →